Evidence map›Paper›PMID 27729478›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2016

Contribution of GABAA, Glycine, and Opioid Receptors to Sacral Neuromodulation of Bladder Overactivity in Cats.

Xuewen Jiang, Thomas W Fuller, Jathin Bandari, Utsav Bansal, Zhaocun Zhang, Bing Shen, Jicheng Wang, James R Roppolo, William C de Groat, Changfeng Tai

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Pathways and parameters of sacral neuromodulation in rats.American journal of physiology. Renal physiology · 2023
    Article
  3. Sacral neuromodulation of bladder underactivity induced by prolonged pudendal afferent firing in cats.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  4. Review
  5. [Application and progress of neuromodulation in lower urinary tract dysfunction].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Glutamatergic Mechanisms Involved in Bladder Overactivity and Pudendal Neuromodulation in Cats.The Journal of pharmacology and experimental therapeutics · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xuewen JiangDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Thomas W FullerDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Jathin BandariDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Utsav BansalDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Zhaocun ZhangDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Bing ShenDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Jicheng WangDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
James R RoppoloDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
William C de GroatDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.).
Changfeng TaiDepartment of Urology, Qilu Hospital, Shandong University, Jinan, P.R. China (X.J., Z.Z.); Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania (X.J., T.W.F., J.B., U.B., Z.Z., B.S., J.W., C.T.); and Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania (J.R.R., W.C.d.G., C.T.) cftai@pitt.edu.
Qilu Hospital of Shandong University · CNUniversity of Pittsburgh · US

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Caterina Rosano · 2004 to 2026
$28.6M
Pitt Integrated Clinical and Geroscience Research Training ProgramT32AG021885 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Aditi U Gurkar · 2003 to 2026
$6.7M
Bladder Nociception: function/central projection of Sympathetic Afferent PathwayR01DK091253 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 2011 to 2015
$1.7M
Neurotransmitter Receptors Involved in Neuromodulation of Bladder OveractivityR01DK102427 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2014 to 2017
$924k
Central Sites of Action for Bladder NeuromodulationR01DK094905 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAI, CHANGFENG · 2013 to 2016
$922k
NIA NIH HHS P30 AG024827NIA NIH HHS T32 AG021885NIDDK NIH HHS R01 DK091253NIDDK NIH HHS R01 DK094905NIDDK NIH HHS R01 DK102427
6 · The paper itself

Abstract

In α-chloralose-anesthetized cats, we examined the role of GABA

Indexed as

Spinal NervesAnimalsCatsElectric StimulationFemaleMaleNaloxonePicrotoxinReceptors, GABA-AReceptors, GlycineReceptors, OpioidStrychnineUrinary Bladder, OveractiveNaloxonePicrotoxinReceptors, GABA-AReceptors, GlycineReceptors, OpioidStrychnine

Identifiers

PMID27729478
PMCPMC5118644
OpenAlexW2531752680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.